$Phase I/Ib Study of Tenalisib (RP6530), a Dual PI3K δ/γ Inhibitor in Patients with Relapsed/Refractory T-Cell Lymphoma$

Phase I/Ib Study of Tenalisib (RP6530), a Dual PI3K δ/γ Inhibitor in Patients with Relapsed/Refractory T-Cell Lymphoma

Tenalisib (RP6530), a dual phosphoinositide 3-kinase δ/γ inhibitor was evaluated in a phase I/Ib study for maximum tolerated dose (MTD), pharmacokinetics, and efficacy in patients with relapsed/refractory peripheral and cutaneous T-Cell Lymphoma (TCL). Histologically confirmed (TCL) patients, with ≥...

Full description

Bibliographic Details
Main Authors:	Auris Huen, Bradley M. Haverkos, Jasmine Zain, Ramchandren Radhakrishnan, Mary Jo Lechowicz, Sumana Devata, Neil J. Korman, Lauren Pinter-Brown, Yasuhiro Oki, Prajak J. Barde, Ajit Nair, Kasi Viswanath Routhu, Srikant Viswanadha, Swaroop Vakkalanka, Swaminathan P. Iyer
Format:	Article
Language:	English
Published:	MDPI AG 2020-08-01
Series:	Cancers
Subjects:	maximum tolerated dose dose limiting toxicity PTCL CTCL
Online Access:	https://www.mdpi.com/2072-6694/12/8/2293

Similar Items

Genomics of Peripheral T-Cell Lymphoma and Its Implications for Personalized Medicine
by: Yumeng Zhang, et al.
Published: (2020-06-01)

Peripheral T cell lymphoma after chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS): a case report
by: Xiao-hang Liu, et al.
Published: (2019-11-01)

Pralatrexate for Prolonged Treatment of Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified, with Prophylactic Leucovorin
by: Koichi Kitazume, et al.
Published: (2019-07-01)

Baseline total lesion glycolysis combined with interim positron emission tomography‐computed tomography is a robust predictor of outcome in patients with peripheral T‐cell lymphoma
by: Akihiro Kitadate, et al.
Published: (2020-08-01)

Epstein-Barr virus positive peripheral T cell lymphoma with novel variants in STAT5B of a pediatric patient: a case report
by: Zihang Chen, et al.
Published: (2018-04-01)

Forodesine in the treatment of relapsed/refractory peripheral T-cell lymphoma: an evidence-based review
by: Makita S, et al.
Published: (2018-04-01)

Novel targeted therapies of T cell lymphomas
by: Katarzyna Iżykowska, et al.
Published: (2020-12-01)

Primary epiglottic follicular variant of peripheral T-cell lymphoma
by: Jienan Kong, et al.
Published: (2019-01-01)

Silent T-cell receptor cutaneous T-cell lymphoma associated to a clonal plasma cell proliferation
by: Ana Caballero, et al.
Published: (2019-02-01)

ITK inhibition induced in vitro and in vivo anti-tumor activity through downregulating TCR signaling pathway in malignant T cell lymphoma
by: Yalu Liu, et al.
Published: (2019-02-01)

Quantificazione mediante PCR dell’EBV-DNA da biopsie cutanee di pazienti con linfomi cutanei primitivi (micosi fungoide e sindrome di Sèzary)
by: Chiara Merlino, et al.
Published: (2007-06-01)

Spotlight on Mogamulizumab-Kpkc for Use in Adults with Relapsed or Refractory Mycosis Fungoides or Sézary Syndrome: Efficacy, Safety, and Patient Selection
by: Blackmon AL, et al.
Published: (2020-09-01)

Role of Haematopoietic Stem Cell Transplantation in Peripheral T-Cell Lymphoma
by: Chathuri Abeyakoon, et al.
Published: (2020-10-01)

Aggressive CD4–CD8–CD45RA+CCR10– Primary Cutaneous Peripheral T-cell Lymphoma, Not Otherwise Specified: A Case Report
by: Natsumi Ikumi, et al.
Published: (2019-09-01)

Peripheral T-cell lymphomas: A review of current approaches and hopes for the future.
by: Alan Pierre Skarbnik, et al.
Published: (2013-05-01)

Constitutive PSGL-1 Correlates with CD30 and TCR Pathways and Represents a Potential Target for Immunotherapy in Anaplastic Large T-Cell Lymphoma
by: Beatrice Belmonte, et al.
Published: (2021-06-01)

B-cell lymphoma 2 inhibitor venetoclax treatment of a patient with cutaneous T-cell lymphoma
by: Amber Loren O. King, BA, et al.
Published: (2021-02-01)

Biomarker-driven management strategies for peripheral T cell lymphoma
by: Erin Mulvey, et al.
Published: (2020-05-01)

Sarcoidosis-Lymphoma Syndrome Associated with Folliculotropic Peripheral T Cell Lymphoma Not Otherwise Specified
by: Saaya Yoshida, et al.
Published: (2017-04-01)

Burrowing through the heterogeneity: Review of mouse models of PTCL-NOS
by: Christine E Cutucache, et al.
Published: (2016-09-01)

The role of pre-treatment and mid-treatment 18F-FDG PET/CT imaging in evaluating prognosis of peripheral T-cell lymphoma-not otherwise specified (PTCL-NOS)
by: Yafei Zhang, et al.
Published: (2021-10-01)

Nivolumab-associated cutaneous T-cell lymphoma
by: Jennifer A. Marks, MD, et al.
Published: (2021-03-01)

Photochemotherapy Induces Interferon Type III Expression via STING Pathway
by: Edyta Biskup, et al.
Published: (2020-11-01)

Key Role of Reactive Oxygen Species (ROS) in Indirubin Derivative-Induced Cell Death in Cutaneous T-Cell Lymphoma Cells
by: Marwa Y. Soltan, et al.
Published: (2019-03-01)

From Early Immunomodulatory Triggers to Immunosuppressive Outcome: Therapeutic Implications of the Complex Interplay Between the Wavebands of Sunlight and the Skin
by: Pablo A. Vieyra-Garcia, et al.
Published: (2018-09-01)

Alopecia-Areata Like Alopecia in Mycosis Fungoides, a Case Report
by: F. Farnaghi, et al.
Published: (1998-04-01)

Cell membrane permeability and defective G2/M block as factors potentially contributing to increased cell chemosensitivity. SeAx cell line as an example
by: Edyta Biskup, et al.
Published: (2021-07-01)

Establishment of Diagnostic Reference Levels and Estimation of Effective Dose from Computed Tomography Head Scans at a Tertiary Hospital in South Africa
by: Mpumelelo Nyathi
Published: (2020-03-01)

Can use of pictograms reduce liquid medication administration errors by mothers? An interventional study
by: Pawan Patidar, et al.
Published: (2021-06-01)

Belinostat in combination with standard cyclophosphamide, doxorubicin, vincristine and prednisone as first-line treatment for patients with newly diagnosed peripheral T-cell lymphoma
by: Patrick B. Johnston, et al.
Published: (2021-02-01)

Molecular heterogeneity in peripheral T-cell lymphoma, not otherwise specified revealed by comprehensive genetic profiling
by: Watatani, Yosaku
Published: (2020)

Response Type and Host Species may be Sufficient to Predict Dose-Response Curve Shape for Adenoviral Vector Vaccines
by: John Benest, et al.
Published: (2020-03-01)

Dosage and Duration of Methylprednisolone Therapy Affect the Occurrence of Cushing Habitus in Patients with Systemic Lupus Erythematosus
by: Didi Permana, et al.
Published: (2019-01-01)

Evaluation of dosing strategy for pembrolizumab for oncology indications
by: Tomoko Freshwater, et al.
Published: (2017-05-01)

Radioproteção, dose e risco em exames radiográficos nos seios da face de crianças, em hospitais de Belo Horizonte, MG Radioprotection, doses and risks in the radiological assessment of paranasal sinuses in children, in hospitals of Belo Horizonte, MG
by: Marco Aurélio de Sousa Lacerda, et al.
Published: (2007-12-01)

Total skin electron beam therapy as palliative treatment for cutaneous manifestations of advanced, therapy-refractory cutaneous lymphoma and leukemia
by: Hauswald Henrik, et al.
Published: (2012-07-01)

Patterns of Gene Expression in Cutaneous T-Cell Lymphoma: Systematic Review of Transcriptomic Studies in Mycosis Fungoides
by: Melika Motamedi, et al.
Published: (2021-06-01)

Desenvolvimento de uma metodologia para calibração de câmaras de ionização de placas paralelas em feixes de raios X de energia baixa em termos de dose absorvida em água
by: OLIVEIRA, CAMILA T. de
Published: (2015)

Desenvolvimento de uma metodologia para calibração de câmaras de ionização de placas paralelas em feixes de raios X de energia baixa em termos de dose absorvida em água
by: OLIVEIRA, CAMILA T. de
Published: (2015)

Dosimetry in dentistry
by: M L Asha, et al.
Published: (2015-01-01)

Cannot write session to /tmp/vufind_sessions/sess_d6i00oocs8ti6o1t7sajvege5h